# Medical Properties Trust Inc. (MPT) fundamentals

Data as of 2026-09-08. NYSE, United States. Sector: Real Estate / Equity Real Estate Investment Trusts (REITs). Price $4.01, market value $2.4 billion.

## Valuation
- **P/E (trailing): n/a** (negative earnings). Medical Properties Trust Inc. reported negative earnings over the last twelve months, so the P/E is not meaningful; use price-to-sales, EV/EBITDA and free-cash-flow yield instead.
- **PEG: 0.45**. A PEG of 0.45 means the P/E is low relative to expected earnings growth: the market is not paying much for that growth.
- **Price / sales: 2.3×**. Each dollar of revenue is priced at 2.3×.
- **Price / book: 0.5×**. The shares trade below book value, which can signal a bargain or a balance sheet the market doubts.

## Profitability
- **Net margin: -28.5%**. The company reported a net loss over the last twelve months.
- **Return on equity: -6.0%**. Return on equity is negative because earnings are negative.
- **Return on assets: -0.2%**. Each dollar of assets produces -0.2% of profit.

## Growth
- **Revenue growth (1 yr): -2.4%** (3-yr -14.3%/yr, 5-yr -4.9%/yr). Revenue fell 2.4% over the last year, against -4.9% a year compounded over five years: growth is accelerating.
- **EPS growth (1 yr): 88.6%**. Earnings per share rose 88.6%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Debt to equity: 2.11**. Debt is 2.11 times equity, a leveraged balance sheet, which is normal for real estate.
- **Piotroski F-score: 3/9**. 3 of 9 checks pass: weak or deteriorating financials.

## Dividends
- **Dividend yield: 8.98%** ($0.35 per share, trailing). Medical Properties Trust Inc. yields 8.98%, high enough to check carefully: yields this high often precede a cut.
- **Dividend growth (5 yr): -21.1%/yr** (1-yr -28.3%). The dividend has not grown over five years.

## Analyst view
- **Analyst consensus: hold** (7 analysts). 7 analysts cover Medical Properties Trust Inc.; the consensus is hold, with an average price target of $4.94 (+23% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): -3.2%** (YTD -16.7%, 3-mo -17.9%). The shares are down 3.2% over twelve months including dividends.
- **From 52-week high: -38.0%** (3.1% above the low). Trading 38% below its 52-week high, deep in a drawdown.
- **200-day average: below**. The price sits below its 200-day moving average, the usual definition of a downtrend.
- **RSI (14-day): 38**. An RSI of 38 is neutral.
- **Beta (1 yr): 0.31** (volatility 37%). Beta of 0.31 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=MPT · Page: https://foliofundamentals.com/stocks/mpt

Not investment advice.